| Therapeutic options for the 2019 novel coronavirus (2019-nCoV) G Li, E De Clercq Nature reviews Drug discovery 19 (3), 149-150, 2020 | 2003 | 2020 |
| Approved antiviral drugs over the past 50 years E De Clercq, G Li Clinical microbiology reviews 29 (3), 695-747, 2016 | 1449 | 2016 |
| Epidemiological and clinical characteristics of the COVID-19 epidemic in Brazil WM de Souza, LF Buss, DS Candido, JP Carrera, S Li, AE Zarebski, ... Nature human behaviour 4 (8), 856-865, 2020 | 446 | 2020 |
| Multi-dimensional classification with Bayesian networks C Bielza, G Li, P Larranaga International Journal of Approximate Reasoning 52 (6), 705-727, 2011 | 270 | 2011 |
| Therapeutic strategies for COVID-19: progress and lessons learned G Li, R Hilgenfeld, R Whitley, E De Clercq Nature Reviews Drug Discovery 22 (6), 449–475, 2023 | 213 | 2023 |
| Current therapy for chronic hepatitis C: The role of direct-acting antivirals G Li, E De Clercq Antiviral research 142, 83-122, 2017 | 194 | 2017 |
| High-throughput analysis of human cytomegalovirus genome diversity highlights the widespread occurrence of gene-disrupting mutations and pervasive recombination S Sijmons, K Thys, M Mbong Ngwese, E Van Damme, J Dvorak, ... Journal of virology 89 (15), 7673-7695, 2015 | 181 | 2015 |
| An integrated map of HIV genome-wide variation from a population perspective G Li, S Piampongsant, NR Faria, A Voet, AC Pineda-Peña, R Khouri, ... Retrovirology 12 (1), 1-18, 2015 | 157 | 2015 |
| HIV genome-wide protein associations: a review of 30 years of research G Li, E De Clercq Microbiology and Molecular Biology Reviews 80 (3), 679-731, 2016 | 142 | 2016 |
| TRIM21 promotes innate immune response to RNA viral infection through Lys27-linked polyubiquitination of MAVS B Xue, H Li, M Guo, J Wang, Y Xu, X Zou, R Deng, G Li, H Zhu Journal of virology 92 (14), 10.1128/jvi. 00321-18, 2018 | 122 | 2018 |
| Clinical significance of chemokine receptor antagonists M Miao, E De Clercq, G Li Expert opinion on drug metabolism & toxicology 16 (1), 11-30, 2020 | 110 | 2020 |
| Low-dose anti-angiogenic therapy sensitizes breast cancer to PD-1 blockade Q Li, Y Wang, W Jia, H Deng, G Li, W Deng, J Chen, BYS Kim, W Jiang, ... Clinical Cancer Research 26 (7), 1712-1724, 2020 | 99 | 2020 |
| Current and emerging non-nucleoside reverse transcriptase inhibitors (NNRTIs) for HIV-1 treatment Y Wang, E De Clercq, G Li Expert opinion on drug metabolism & toxicology 15 (10), 813-829, 2019 | 88 | 2019 |
| NLRX1 mediates MAVS degradation to attenuate the hepatitis C virus-induced innate immune response through PCBP2 Y Qin, B Xue, C Liu, X Wang, R Tian, Q Xie, M Guo, G Li, D Yang, H Zhu Journal of virology 91 (23), 10.1128/jvi. 01264-17, 2017 | 86 | 2017 |
| Genetic diversity and selective pressure in hepatitis C virus genotypes 1–6: significance for direct-acting antiviral treatment and drug resistance L Cuypers, G Li, P Libin, S Piampongsant, AM Vandamme, K Theys Viruses 7 (9), 5018-5039, 2015 | 83 | 2015 |
| Mortality risk of COVID-19 in elderly males with comorbidities: a multi-country study G Li, Y Liu, X Jing, Y Wang, M Miao, L Tao, Z Zhou, Y Xie, Y Huang, J Lei, ... Aging (Albany NY) 13 (1), 27, 2021 | 80 | 2021 |
| Antibody seroconversion in asymptomatic and symptomatic patients infected with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) C Jiang, Y Wang, M Hu, L Wen, C Wen, Y Wang, W Zhu, S Tai, Z Jiang, ... Clinical & translational immunology 9 (9), e1182, 2020 | 79 | 2020 |
| Functional conservation of HIV-1 Gag: implications for rational drug design G Li, J Verheyen, SY Rhee, A Voet, AM Vandamme, K Theys Retrovirology 10, 1-11, 2013 | 77 | 2013 |
| Long noncoding RNA ITPRIP-1 positively regulates the innate immune response through promotion of oligomerization and activation of MDA5 Q Xie, S Chen, R Tian, X Huang, R Deng, B Xue, Y Qin, Y Xu, J Wang, ... Journal of virology 92 (17), 10.1128/jvi. 00507-18, 2018 | 66 | 2018 |
| DsbA-L mediated renal tubulointerstitial fibrosis in UUO mice X Li, J Pan, H Li, G Li, X Liu, B Liu, Z He, Z Peng, H Zhang, Y Li, X Xiang, ... Nature communications 11 (1), 4467, 2020 | 65 | 2020 |
